Tissue Repair Ltd (ASX: TRP) Share Price and News

Price

$0.17

Movement

0.00 (0.0)

as at 24 Jun - Closed (20 mins delayed)

52 Week Range

$0.165 - $0.50

 
1 Year Return

-20.93%

Tissue Repair Ltd Chart and Price Data

2025
2025
2025
2025
$0.10
$0.20
$0.30
$0.40
$0.10
$0.20
$0.30
$0.40
$0.10
$0.20
$0.30
$0.40
$0.10
$0.20
$0.30
$0.40

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $10.28 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 60.46 million
Earnings per share -0.070
Dividend per share N/A
Year To Date Return -39.29%
Earnings Yield N/A
Franking -
Share Price

$0.17

Day Change

0.00 (0.0)

52 Week Range

$0.165 - $0.50

Yesterday's Close

$0.17

Today's Open

Days Range

-

Volume

0

Avg. Volume (1 month)

23,581

Turnover

$0

as at 24 Jun - Closed

  • Tissue Repair Ltd (ASX: TRP)
    Latest News

    Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
    Healthcare Shares

    2 ASX biotech shares rocketing more than 40% on big news

    These two ASX healthcare companies have exciting news for investors today.

    Read more »

    Codan share price A dismayed kid dressed as a scientist stands with his back to a rocket crashed into the ground
    IPOs

    IPO flop: Tissue Repair (ASX:TRP) share price plunges 40% since listing

    The biotech company's initial public offering (IPO) has not gone as well as some investors might have hoped. Here's the…

    Read more »

    TRP ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    30th Apr 2025 2025-04-30T09:44:23 Quarterly Activities/Appendix 4C Cash Flow ReportYesNo9:44am111.4M
    1st Apr 2025 2025-04-01T09:42:45 Appointment of Chief Financial OfficerYesNo9:42am1128k
    27th Feb 2025 2025-02-27T16:37:02 Appendix 4D and Half Year Report to 31 December 2024YesNo4:37pm19426k
    31st Jan 2025 2025-01-31T11:46:34 Quarterly Activities/Appendix 4C Cash Flow ReportYesNo11:46am10425k
    29th Jan 2025 2025-01-29T15:17:37 Phase 3 Clinical Trial Programme for TR987YesNo3:17pm5614k
    5th Dec 2024 2024-12-05T15:24:51 Change of AddressYesNo3:24pm1166k
    13th Nov 2024 2024-11-13T14:20:03 Change of Director's Interest Notice - Tony ChararaYesNo2:20pm4637k
    13th Nov 2024 2024-11-13T14:13:23 Notification regarding unquoted securities - TRPYesNo2:13pm719k
    29th Oct 2024 2024-10-29T17:05:04 Initial Director's Interest Notice - AMYesNo5:05pm2942k
    29th Oct 2024 2024-10-29T10:59:42 Initial Director's Interest Notice - PKYesNo10:59am2918k

    About Tissue Repair Ltd

    Tissue Repair Ltd is a clinical-stage biopharmaceutical company engaged in development of wound healing products for chronic wounds and the aftercare of cosmetic procedures, with the potential for further development of related technologies.

    TRP Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    23 Jun 2025 $0.17 $0.00 0.00% 39,333 $0.17 $0.17 $0.17
    20 Jun 2025 $0.18 $0.00 0.00% 80,052 $0.18 $0.18 $0.17
    13 Jun 2025 $0.17 $0.00 0.00% 1,270 $0.17 $0.17 $0.17
    12 Jun 2025 $0.17 $-0.01 -5.56% 2,560 $0.17 $0.17 $0.17
    11 Jun 2025 $0.18 $0.00 0.00% 164 $0.18 $0.18 $0.18
    10 Jun 2025 $0.18 $0.00 0.00% 85,595 $0.18 $0.18 $0.18
    06 Jun 2025 $0.18 $0.00 0.00% 11,484 $0.18 $0.18 $0.18
    05 Jun 2025 $0.18 $-0.01 -5.41% 20,258 $0.17 $0.18 $0.17
    04 Jun 2025 $0.19 $0.00 0.00% 95,206 $0.18 $0.19 $0.18
    28 May 2025 $0.19 $0.00 0.00% 87,612 $0.19 $0.19 $0.18

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    12 Nov 2024 Tony Charara Issued 750,000 $191,250
    Issue of options.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Tony Charara Co-FounderExecutive Director May 2012
    Mr Charara is a co-founder of Tissue Repair. He has been involved in the Company's clinical development program, across its two-phase 2B trials, commercialization strategy and overall operations. Tony is an investment banker by background and has experience across early-stage venture assets and in advising technology companies at ANZ Investment Bank, Ord Minnett Securities and JPMorgan in their investment banking teams. Tony is also a co-founder of Mable Technologies, an online marketplace and health technology platform operating in the aged care and disability sectors.
    Mr Alistair Gregory McKeough Non-Executive Director Oct 2024
    Mr McKeough has experience as a director of private and listed corporations in many sectors, including professional services, corporate services, regulatory technology, sports technology, charities, education and biotech. He was formerly Head of Professional Services at Automic Group, where he led the legal and company secretarial teams. Mr McKeough is currently a non-executive director of Recce Pharmaceuticals Ltd (ASX:RCE). Mr McKeough will serve as Chair of TRPs board.
    Mr Patryk Kania Non-Executive Director Oct 2024
    Mr Kania is a medical device executive and brings over 20 years commercialisation and leadership experience in Medical Devices, Pharma, and Health Technologies, within sales and marketing management, and general management, working across the US, Europe and APAC. Mr Kanias commercial experience spans public organisations and early stage start-ups. Patryk is CEO and President USA, and Managing Director of Field Orthopaedics Ltd. He has previously held senior roles at Smith Nephew, Abbott, J&J Medical and Roche. Patryk also currently serves as non-executive director of EMVision Medical Devices Ltd (ASX:EMV).
    Ms Sushma Kejriwal Company Secretary Mar 2024
    -
    Sushma Kejriwal Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Selene Holdings Ltd 5,955,980 9.85%
    Spark Capital Pty Limited 4,822,260 7.98%
    Creight Investments Pty Ltd <987 Trust A/C> 3,031,720 5.01%
    Welas Pty Ltd <Wales Family Trust A/C> 2,317,580 3.83%
    Mark Deacon Shaw 2,035,160 3.37%
    Hishenk Pty Ltd 2,000,000 3.31%
    Bannaby Investments Pty Limited 1,690,580 2.80%
    Moore Family Nominee Pty Limited 1,217,400 2.01%
    Gidley Baird Holdings Pty Ltd 1,055,440 1.75%
    Mr Guy Banducci & Mrs Lisa Maree Banducci <Kali Super Fund A/C> 1,050,000 1.74%
    Super Secrety Pty Limited <Tkocs Sf A/C> 1,050,000 1.74%
    Creight Investments Pty Ltd <Scutt Retirement Fund A/C> 990,540 1.64%
    Warwick Nettle Pty Limited <Warwick Nettle Superannuationfund A/C> 967,040 1.60%
    Phytose Corporatn Limited <Boundaryone S/F A/C> 793,940 1.31%
    Terrence Joseph Caplice 730,440 1.21%
    Citicorp Nominees Pty Limited 687,913 1.14%
    Dc Scutt Pty Ltd <Dcs Pension A/C> 642,095 1.06%
    Cinderella Management Company Pty Ltd <The Cinderella Unit A/C> 608,694 1.01%
    Rg Roden Pty Limited 608,680 1.01%
    Mr Paul Maxwell Bide 600,000 0.99%
    Bmy Group Pty Ltd 543,478 0.90%

    Profile

    since

    Note